Genpharmasec Confirms Nil Deviation in Rights Issue Proceeds Utilization for Sep'26 Quarter
Genpharmasec Ltd 路 Others (Uncategorized) 路 03 Nov 2026, 11:16 pm
Genpharmasec Confirms Nil Deviation in Rights Issue Proceeds Utilization for Sep'26 Quarter Genpharmasec Limited reported zero deviation or variation in utilizing proceeds from its Rights Issue (allotted 21st Feb'24) for the quarter ended 30th Sep'26. Out of Rs. 4,845.05 Lakhs total raised, key allocations include Rs. 1,650.00 Lakhs fully utilized for working capital, Rs. 1,443.58 Lakhs fully utilized to acquire shares in Derren Healthcare Private Limited, Rs. 1,138.47 Lakhs for general corporate purposes, and Rs. 25.00 Lakhs for issue expenses. Additionally, Rs. 289.00 Lakhs has been utilized toward debt repayment out of an allocated Rs. 588.00 Lakhs.
Original exchange filing (PDF)
More announcements from Genpharmasec Ltd
- Outcome of the Meeting of Board of Directors held on Tuesday, 03rd November, 2026. 路 03 Nov 2026
- Unaudited Standalone & consolidated Financial Result of the company for the quarter & half year ended 30th September 2026. 路 03 Nov 2026
- Outcome of the Meeting of Board of Directors held on Tuesday, 03rd November, 2026. 路 03 Nov 2026
- Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve 1. To consider and approve Un-audited .... 路 03 Nov 2026
- Intimation under regulation 30 - Change of name of Subsidiary of the company. 路 14 Oct 2026
- Disclosure of Voting Results and Scrutinizers report of the 34th Annual General Meeting held on 29th September, 2026. 路 30 Sept 2026
- Submission of Proceeding of the 34th Annual General Meeting of the Member of the Genpharmasec Ltd held on Tuesday, 29th September, 2026. 路 29 Sept 2026
- Annual Report for Financial Year 2025-26. 路 07 Sept 2026
